185559-52-8Relevant articles and documents
Synthesis of azabicyclo[3.1.0]amine analogues of anacardic acid as potent antibacterial agents
Vempati, Ravi Kumar,Reddy,Alapati, Srinivasa Rao,Dubey
, p. 986 - 994 (2013/06/26)
Azabicyclo[3.1.0]amine analogues of anacardic acid (16a, 16b, 18a, 18b, 19 and 19b) were synthesized from anacardic acid and tested for their antibacterial activity against Gram positive and Gram negative bacteria. Most of the compounds are having potency at par with ampicillin and inferior with other standard drugs.
Discovery of conformationally rigid 3-azabicyclo[3.1.0]hexane-derived dipeptidyl peptidase-IV inhibitors
Sattigeri, Jitendra A.,Andappan, Murugaiah M.S.,Kishore, Kaushal,Thangathirupathy, Srinivasan,Sundaram, Sinduja,Singh, Shuchita,Sharma, Suchitra,Davis, Joseph A.,Chugh, Anita,Bansal, Vinay S.
scheme or table, p. 4087 - 4091 (2009/04/10)
The induction of conformationally restricted N-(aryl or heteroaryl)-3-azabicyclo[3.1.0]hexane derivatives at P2 region of compounds of 2-cyanopyrrolidine class was explored to develop novel DPP-IV inhibitors. The synthesis, structure-activity r
AZABICYCLIC MUSCARINIC RECEPTOR ANTAGONISTS
-
Page/Page column 43, (2010/11/08)
The present invention generally relates to muscarinic receptor antagonists, which are useful for treating various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to processes for preparing compounds described herein, pharmaceutical compositions containing the disclosed compounds, and the methods for treating diseases mediated through muscarinic receptors.